by Emily C | May 12, 2020 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory, Uncategorized
Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...
by Jennifer P | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory
Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...
by Jennifer P | Apr 24, 2019 | Cosmetics, OTC Drugs, Research/Science/Technology, U.S. Regulatory
Amway, an American multi-level marketing company that sells health, beauty, and home care products, has approached a new take on improving their business before outsider digital technology disrupts it. They recently teamed up with Texas-based software company, Kony,...
by Jennifer P | Apr 17, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs
Health Canada is working towards improving the way self-care products (cosmetics, NHPs, and non-prescription drugs) are regulated in Canada. These changes will be implemented via the “Self-Care Framework” to regulate low-risk self care products in the same way, and...
by Jennifer P | Jan 16, 2019 | Canadian Regulatory
What is a risk assessment of a chemical substance? A risk assessment is an integral part of maintaining both the health of Canadians and the environment. Risk assessments are executed by Environment and Climate Change Canada under the CEPA (Canadian Environmental...
Recent Comments